Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Critical Care Strategic Clinical Network, Alberta Health Services, Alberta, Canada.
J Crit Care. 2024 Jun;81:154524. doi: 10.1016/j.jcrc.2024.154524. Epub 2024 Jan 10.
The ABCDEF bundle may improve delirium outcomes among intensive care unit (ICU) patients, however population-based studies are lacking. In this study we evaluated effects of a quality improvement initiative based on the ABCDEF bundle in adult ICUs in Alberta, Canada.
We conducted a pre-post, registry-based clinical trial, analysed using interrupted time series methodology. Outcomes were examined via segmented linear regression using mixed effects models. The main data source was a population-based electronic health record.
44,405 consecutive admissions (38,400 unique patients) admitted to 15 general medical/surgical and/or neurologic adult ICUs between 2014 and 2019 were included. The proportion of delirium days per ICU increased from 30.24% to 35.31% during the pre-intervention period. After intervention implementation it decreased significantly (bimonthly decrease of 0.34%, 95%CI 0.18-0.50%, p < 0.01) from 33.48% (95%CI 29.64-37.31%) in 2017 to 28.74% (95%CI 25.22-32.26%) in 2019. The proportion of sedation days using midazolam demonstrated an immediate decrease of 7.58% (95%CI 4.00-11.16%). There were no significant changes in duration of invasive ventilation, proportion of partial coma days, ICU mortality, or potential adverse events.
An ABCDEF delirium initiative was implemented on a population-basis within adult ICUs and was successful at reducing the prevalence of delirium.
ABCDEF 集束干预可能改善重症监护病房(ICU)患者的谵妄结局,但目前缺乏基于人群的研究。本研究评估了基于 ABCDEF 集束的质量改进措施在加拿大艾伯塔省成人 ICU 中的效果。
我们进行了一项前后对照、基于注册的临床试验,采用中断时间序列方法进行分析。使用混合效应模型的分段线性回归来评估结果。主要数据来源是基于人群的电子健康记录。
纳入了 2014 年至 2019 年间 15 个普通内科/外科和/或神经科成人 ICU 连续收治的 44405 例(38400 例)患者。ICU 谵妄天数的比例在干预前期间从 30.24%增加到 35.31%。干预实施后,它显著下降(每两个月下降 0.34%,95%CI 0.18-0.50%,p<0.01),从 2017 年的 33.48%(95%CI 29.64-37.31%)降至 2019 年的 28.74%(95%CI 25.22-32.26%)。咪达唑仑镇静天数立即下降了 7.58%(95%CI 4.00-11.16%)。侵入性通气时间、部分昏迷天数、ICU 死亡率或潜在不良事件均无显著变化。
在成人 ICU 中基于人群实施了 ABCDEF 谵妄干预措施,成功降低了谵妄的发生率。